20 related articles for article (PubMed ID: 38458365)
1. Selective muscle involvement in a family affected by a second LIM domain mutation of fhl1: an imaging study using computed tomography.
Komagamine T; Kawai M; Kokubun N; Miyatake S; Ogata K; Hayashi YK; Nishino I; Hirata K
J Neurol Sci; 2012 Jul; 318(1-2):163-7. PubMed ID: 22541254
[TBL] [Abstract][Full Text] [Related]
2. [Childhood reducing body myopathy caused by FHL1 gene variation in a child].
Wei CJ; Wang ZX; Chang XZ; Lyu JL; Ge L; Fan YB; Zhang YH; Xiong H
Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):147-149. PubMed ID: 32102154
[TBL] [Abstract][Full Text] [Related]
3. 199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands.
Bertrand AT; Bönnemann CG; Bonne G;
Neuromuscul Disord; 2014 May; 24(5):453-62. PubMed ID: 24613424
[No Abstract] [Full Text] [Related]
4. Adverse clinical course and poor prognosis of hypertrophic cardiomyopathy due to mutations in FHL1.
Gallego-Delgado M; Gonzalez-Lopez E; Garcia-Guereta L; Ortega-Molina M; Gonzalez-Vioque E; Cobo-Marcos M; Alonso-Pulpon L; Garcia-Pavia P
Int J Cardiol; 2015 Jul; 191():194-7. PubMed ID: 25965631
[No Abstract] [Full Text] [Related]
5. Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues.
Shathasivam T; Kislinger T; Gramolini AO
J Cell Mol Med; 2010 Dec; 14(12):2702-20. PubMed ID: 20874719
[TBL] [Abstract][Full Text] [Related]
6. The role of FHL1 in tumors.
Zeng Q; Jiang T
Gene; 2024 Jun; 911():148347. PubMed ID: 38458365
[No Abstract] [Full Text] [Related]
7. Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression.
Wei X; Zhang H
Cancer Biol Med; 2020 May; 17(2):270-281. PubMed ID: 32587768
[TBL] [Abstract][Full Text] [Related]
8. Reducing body myopathy and other FHL1-related muscular disorders.
Schessl J; Feldkirchner S; Kubny C; Schoser B
Semin Pediatr Neurol; 2011 Dec; 18(4):257-63. PubMed ID: 22172421
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
